HCMT
EBS icon

Highland Capital Management (Tennessee)’s Emergent Biosolutions EBS Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-292
Closed -$8K – 365
2015
Q3 		$8K Hold
292
– – ﹤0.01% 509
2015
Q2 		$10K Buy
+292
New +$9.05K ﹤0.01% 508

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Highland Capital Management (Tennessee)'s EBS Position: Q4 2015 in Review

Highland Capital Management (Tennessee) sold out of Emergent Biosolutions (EBS) in Q4 2015, closing a stake of 292 shares — an estimated $8K sold.

Highland Capital Management (Tennessee) first reported a position in EBS in Q2 2015 and held it in 2 quarters. The position peaked at $10K in Q2 2015. 206 funds tracked by Wall St. Rank hold EBS as of Q4 2015.

  • Highland Capital Management (Tennessee) reported no remaining Emergent Biosolutions position as of Q4 2015 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 292 Emergent Biosolutions shares in Q4 2015, an estimated $8K.
  • Highland Capital Management (Tennessee) first reported a position in Emergent Biosolutions in Q2 2015 and held it in 2 quarters.
  • Highland Capital Management (Tennessee)'s Emergent Biosolutions position peaked at $10K in Q2 2015.
  • 206 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2015.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2015, filed 27 Jan 2016.